Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Sex: All
Age: 7 - 70+
Code: NCT01568697
Recruiting
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: New York NY, Baltimore MD, Richmond VA, Margate FL,
Sponsor: NGM Biopharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07033026
Phase2, Recruiting
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
for
Healthy Volunteer
Location: Bethesda MD
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sex: All
Age: 21 - 60
Code: NCT06819189
Phase1, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase3, Recruiting
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
for
Plasmablastic Lymphoma,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 18+
Code: NCT04139304
Early_phase1, Recruiting
Behavioral and Functional Task Development, Implementation, and Testing
for
Alcohol Dependence, Alcohol Drinking, Alcoholism,
Location: Bethesda MD
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sex: All
Age: 18 - 65
Code: NCT02108054
Recruiting
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
for
Overweight, Obesity
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 50
Code: NCT06325722
Recruiting
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
for
Food Hypersensitivity
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 1 - 55
Code: NCT06934200
Phase2, Recruiting
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
for
Mesothelioma, Neoplasms, Stomach Neoplasms,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06885697
Phase1, Recruiting
Long-term Characterization of GOREĀ® TAGĀ® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
Location: Lebanon NH, Hackensack NJ, Norfolk VA, Baltimore MD,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT06658730
Recruiting
Human Movement Database
for
Movement Disorder
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 0 - 70+
Code: NCT00001252
Recruiting
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
for
Tuberculosis
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT04052022
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease